P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
P862：ABBV-383（一种BCMA×CD3双特异性T细胞定向抗体）治疗复发/难治性多发性骨髓瘤的I期首次人体单药治疗研究
期刊:
影响因子:
doi:10.1002/oby.23854
Höchsmann, Christoph; Martin, Corby K; Apolzan, John W; Dorling, James L; Newton, Robert L Jr; Denstel, Kara D; Mire, Emily F; Johnson, William D; Zhang, Dachuan; Arnold, Connie L; Davis, Terry C; Fonseca, Vivian; Thethi, Tina K; Lavie, Carl J; Springgate, Benjamin; Katzmarzyk, Peter T; Weisel, Katja; D’souza, Anita; Hurd, David; Voorhees, Peter; Teipel, Raphael; Chung, Alfred; Rodriguez, Cesar; Tuchman, Sacha; Korde, Neha; Safah, Hana; Bueno, Orlando; Feng, Zhongling; Rosenberg, Tanya; Kumar Pothacamury, Rajvineeth; Ross, Jeremy; Lee, Shane; Jin, Ziyi; Talati, Chetasi; Kumar, Shaji; Vij, Ravi
T细胞
多发性骨髓瘤
CD3
T细胞
骨髓瘤
细胞生物学
免疫/内分泌
